
    
      The total study period for each patient will be 26 weeks (12 plus 12 weeks of intervention
      with a 2 week wash-out period).

      The endpoints will be evaluated at baseline (week 0), at week 12, at week 14 (following 2
      weeks of wash-out) and finally at week 26.
    
  